Insider Transactions Reported by 26 Insiders of Ernexa Therapeutics Inc.

Symbol
ERNA on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Ernexa Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Charles Cherington 10%+ Owner $4.36M +$2.22M +104% 09 Jun 2025
Freebird Partners LP 10%+ Owner $1.5M 14 Dec 2023
GEORGE P. DENNY III 10%+ Owner $1.13M 02 Dec 2022
JOHN D. HALPERN 10%+ Owner $1.12M 02 Dec 2022
Nicholas J. Singer Director $962K 02 Dec 2022
Roger Sidhu Chief Medical Officer $200K 20 Sep 2022
Kevin DAmour Chief Scientific Officer $159K 28 Jun 2022
Sandra Gurrola Sr. VP of Finance $1.1K 21 Jun 2025
Erich Mohr Director 08 Dec 2021
Luba Greenwood Director 08 Dec 2021
Heather B. Redman Director 14 Jan 2022
Jay Sial Chief Administration Officer 11 Mar 2022
ERIN S. ENRIGHT Director 14 Jan 2022
Andrew Jackson Chief Financial Officer 03 Jun 2022
Gregory Fiore Director 01 Aug 2022
Howard J. Federoff CEO & President, Director 11 Mar 2022
DENNIS LANGER Director 08 Dec 2021
Elena Ratner Director 13 Jan 2025
RICHARD W. WAGNER Former director 08 Aug 2023
James Arthur Bristol Director 07 Feb 2025
Peter Cicala Director 07 Feb 2025
William Wexler Director 07 Feb 2025
Matthew Angel President and CEO, Director 12 Jan 2023
Dorothy Clarke General Counsel, Director 01 Jan 2024
Sanjeev Luther President & CEO, Director 07 Feb 2025
BINDER BRANT Former director 08 Aug 2023

Recent Insider Transactions by Companies or Individuals for Ernexa Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.